1ony
Oxalyl-Aryl-Amino Benzoic Acid inhibitors of PTP1B, compound 17
|
OverviewOverview
Protein Tyrosine phosphatase 1B (PTP1B) has been implicated as a key, negative regulator of both insulin and leptin signaling pathways. Using an, NMR-based screening approach with 15N- and 13C-labeled PTP1B, we have, identified 2,3-dimethylphenyloxalylaminobenzoic acid (1) as a general, reversible, and competitive PTPase inhibitor. Structure-based approach, guided by X-ray crystallography facilitated the development of 1 into a, novel series of potent and selective PTP1B inhibitors occupying both the, catalytic site and a portion of the noncatalytic, second phosphotyrosine, binding site. Interestingly, oral biovailability has been observed in rats, for some compounds. Furthermore, we demonstrated in vivo plasma glucose, lowering effects with compound 12d in ob/ob mice.
DiseaseDisease
Known diseases associated with this structure: Abdominal body fat distribution, modifier of OMIM:[176885], Insulin resistance, susceptibility to OMIM:[176885]
About this StructureAbout this Structure
1ONY is a Single protein structure of sequence from Homo sapiens with 588 as ligand. Active as Protein-tyrosine-phosphatase, with EC number 3.1.3.48 Full crystallographic information is available from OCA.
ReferenceReference
Discovery and structure-activity relationship of oxalylarylaminobenzoic acids as inhibitors of protein tyrosine phosphatase 1B., Liu G, Szczepankiewicz BG, Pei Z, Janowick DA, Xin Z, Hajduk PJ, Abad-Zapatero C, Liang H, Hutchins CW, Fesik SW, Ballaron SJ, Stashko MA, Lubben T, Mika AK, Zinker BA, Trevillyan JM, Jirousek MR, J Med Chem. 2003 May 22;46(11):2093-103. PMID:12747781
Page seeded by OCA on Mon Nov 12 18:34:47 2007